|
2025
|
Invention
|
Virus vector production.
An enveloped viral particle producer or packaging cell, wherein the cel... |
|
|
Invention
|
Means and methods for safe and efficient gene editing in cells. The invention is directed to mean... |
|
|
Invention
|
Combinations, inhibitors, viral vectors, methods, and uses for in vivo gene therapy and gene edit... |
|
|
Invention
|
Method for producing t cell progenitors from human pluripotent stem cells. The present invention ... |
|
|
Invention
|
Multifunctional system. The invention is directed to a multifunctional system bearing a ligand ca... |
|
|
Invention
|
Il-10-producing cd4+ t cells and uses thereof.
The present invention relates to a CD4+ T cell th... |
|
|
Invention
|
Chimeric antigen receptor. The present invention provides a chimeric antigen receptor (CAR) compr... |
|
|
Invention
|
Antibodies and uses thereof.
The present invention relates to an antibody or antigen binding fra... |
|
2024
|
Invention
|
Compositions and methods for generating hematopoietic stem cells (hscs).
The present disclosure ... |
|
|
Invention
|
Engineered regulatory t cells and uses thereof. The invention provides a lentiviral vector compri... |
|
|
Invention
|
Milli-scale vessel-like structure, method and device. It forms an object of the present invention... |
|
|
Invention
|
Methods for the purification of viral vectors.
Viral vector production processes and methods of ... |
|
|
Invention
|
Combination of a glycosylation inhibitor with one car cell therapy for treating cancer.
The pres... |
|
|
Invention
|
Polynucleotides. The present invention relates to polynucleotides comprising a nucleotide sequenc... |
|
|
Invention
|
Gene therapy. A vector comprising an astrocyte-specific promoter operably linked to a nucleotide ... |
|
|
Invention
|
Means and methods for genetic modification of uba1. The present invention relates to means and me... |
|
|
Invention
|
Permanent epigenetic gene silencing.
A product comprising two or more artificial transcription r... |
|
|
Invention
|
Novel lentiviral vector particles. in vitro, in vivo ex vivoex vivo, wherein a nucleic acid is tr... |
|
|
Invention
|
T-cell receptors. The present invention provides novel tumour-antigen specific T-cell receptors (... |
|
|
Invention
|
Gtf2i inhibitors and uses thereof. The present invention refers to a molecule for use in the trea... |
|
|
Invention
|
Tcr and peptides.
A T-cell receptor (TCR), which binds to a Wilms tumour 1 protein (WT1) peptide... |
|
|
Invention
|
Gene therapy.
An inhibitor of p53 activation for use in haematopoietic stem and/or progenitor ce... |
|
|
Invention
|
T-cell receptors. The present invention provides a T-cell receptor (TCR) which binds to an immuno... |
|
|
Invention
|
Genetic modification protocols in immune cells. The present invention relates to a method for gen... |
|
|
Invention
|
Vector. A vector for central nervous system (CNS)-specific expression, wherein the vector compris... |
|
|
Invention
|
Device and method for classifying the grade and/or type of cataracts. The present invention conce... |
|
|
Invention
|
Gene therapy. A product comprising: (a) a vector for liver and/or splenic phagocyte-specific expr... |
|
|
Invention
|
Vector production. An enveloped viral particle producer or packaging cell, wherein the cell is mo... |
|
|
Invention
|
Gene therapy. A polynucleotide comprising a nucleotide sequence encoding methyl-CpG binding-prote... |
|
|
Invention
|
Gene therapy. A product comprising: (a) a hematopoietic stem cell (HSC), a hematopoietic progenit... |
|
|
Invention
|
Vector production.
An enveloped viral particle producer or packaging cell, wherein the cell is g... |
|
|
Invention
|
Method for improving retroviral transduction and gene editing in hematopoietic stem cells using c... |
|
|
Invention
|
Lxr antagonists. The present invention relates to novel antagonists of the Liver X Receptors (LXR... |
|
|
Invention
|
T-cell receptors. The present invention provides a T-cell receptor (TCR) which binds to a Human T... |
|
2023
|
Invention
|
Compositions and methods for treating diseases and disorders of the central nervous system.
The ... |
|
|
Invention
|
Transgene cassettes and epigenetic silencers for the treatment of disorders.
An epigenetic silen... |
|
|
Invention
|
Gene therapy.
Use of a combination of (a) cyclosporin H (CsH) or a derivative thereof, and (b) a... |
|
|
Invention
|
Methods for haematopoietic stem cell transplantation.
A method for haematopoietic stem and/or pr... |
|
|
Invention
|
Lentiviral vector.
A lentiviral vector comprising a nucleotide sequence encoding low density lip... |
|
|
Invention
|
Gene therapy.
An adeno-associated viral (AAV) capsid protein, wherein the capsid protein compris... |
|
|
Invention
|
Gene vector.
A gene vector comprising a miRNA sequence target. |
|
|
Invention
|
Fusion proteins and uses thereof.
The present invention refers to: a) at least one peptide recog... |
|
|
Invention
|
Endogenous gene regulation to treat neurological disorders and diseases.
The invention provides ... |
|
2022
|
Invention
|
Polynucleotides useful for correcting mutations in the rag1 gene.
The present invention relates ... |
|
|
Invention
|
Gene therapy.
Use of one or more inhibitor(s) of senescence for increasing the survival and/or e... |
|
|
Invention
|
Engineered transposase and uses thereof.
The present invention relates to an engineered transpos... |
|
|
Invention
|
Image capturing method. An image capturing method (100) using an image capturing apparatus (1) th... |
|
|
Invention
|
Compositions for improving the transduction of cells by viral vectors.
A combination of: (a) at ... |
|
|
Invention
|
Guide rnas and uses thereof.
The present invention is related to an isolated guide ribonucleic a... |
|
2021
|
Invention
|
Vector.
A vector for liver and/or splenic phagocyte-specific expression, wherein the vector comp... |
|
2018
|
P/S
|
Perfume; Perfumery; Cosmetics; Skin and body beauty and care preparations, not for medical purpos... |
|
2014
|
P/S
|
Chemicals for use in industry and science; Chemical substances for preserving foodstuffs. Pharmac... |
|
2007
|
P/S
|
Software for the management of a technical-informative
network among doctors, health care field ... |
